Evidence map›Paper›PMID 40585240›Full record

ArticleResearch square2025

Genomic surveillance uncovers regional variation in HCV transmission networks among people who use drugs in rural U.S. communities.

Damien Tully, David Bean, Jacklyn Sarette, Thang Long Ngo, Karen Power, Daniel Brook, Hannah Cooper, Judith Feinberg, Peter Friedmann, Karli Hochstatter and 14 more

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Damien TullyMedical Research Council / Uganda Virus Research Institute and LSHTM Uganda Research Unit.
David BeanRagon Institute of MGH, MIT and Harvard.
Jacklyn SaretteRagon Institute of MGH, MIT and Harvard.
Thang Long NgoRagon Institute of MGH, MIT and Harvard.
Karen PowerRagon Institute of MGH, MIT and Harvard.
Daniel BrookOhio State University.
Hannah CooperRollins School of Public Health, Emory University.
Judith FeinbergWest Virginia University.
Peter FriedmannUniversity of Massachusetts Chan Medical School.ORCID 0000-0003-3585-3604
Karli HochstatterFriends Research Institute.
Jennifer HavensUniversity of Kentucky College of Medicine.
Shanna BabalonisUniversity of Kentucky College of Medicine.
Christopher HurtUniversity of North Carolina at Chapel Hill.
Wiley JenkinsClemson University.
Todd KorthuisOregon Health & Science University.
William MillerOhio State University.ORCID 0000-0002-1934-7827
Mai PhoUniversity of Chicago.
Gordan SmithWest Virginia University.
Thomas StopkaTufts University School of Medicine.
Judith TsuiUniversity of Washington.
Sarah MixsonUniversity of Washington.
Ryan WestergaardUniversity of Wisconsin-Madison.
April YoungUniversity of Kentucky.
Todd AllenRagon Institute of MGH, MIT and Harvard.

Funding

Increasing Access to Hepatitis C Treatment in Opioid Endemic Rural Areas: the Kentucky Viral Hepatitis Treatment (KeY Treat) StudyR01DA047952 · NIDA · UNIVERSITY OF KENTUCKY · PI HAVENS, JENNIFER R · 2018 to 2023
$8.7M
Examining the Impact of the Twin Epidemics of Methamphetamine and Opioid Use on Overdose, Risky Sex and Treatment Engagement among PWUD in Two Rural Appalachian CohortsR01DA033862 · NIDA · UNIVERSITY OF KENTUCKY · PI Jennifer R Havens · 2012 to 2026
$6.9M
Next-Generation Sequencing Center for GHOSTing Hepatitis C Virus: Transforming Community Based Molecular Surveillance and Outbreak InvestigationU24DA044801 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI ALLEN, TODD M · 2017 to 2022
$3.3M
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)UG3DA044830 · NIDA · BAYSTATE MEDICAL CENTER, INC. · PI FRIEDMANN, PETER D · 2017 to 2018
$1.6M
Community-based, client-centered prevention homes to address the rural opioid epidemicUG3DA044826 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI SEAL, DAVID W, WESTERGAARD, RYAN PATRICK · 2017 to 2018
$1.4M
Kentucky Communities & Researchers Engaging to Halt the Opioid Epidemic-CARE2HOPEUG3DA044798 · NIDA · UNIVERSITY OF KENTUCKY · PI COOPER, HANNAH LF, YOUNG, APRIL MARIE · 2017 to 2018
$1.3M
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) StudyUG3DA044831 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KORTHUIS, PHILIP TODD · 2017 to 2018
$895k
NIDA NIH HHS R01 DA033862NIDA NIH HHS R01 DA047952NIDA NIH HHS U24 DA044801NIDA NIH HHS UG3 DA044798NIDA NIH HHS UG3 DA044826NIDA NIH HHS UG3 DA044830NIDA NIH HHS UG3 DA044831
6 · The paper itself

Abstract

Hepatitis C virus (HCV) remains a significant public health concern in the United States particularly in rural communities where the opioid epidemic has accelerated transmission among people who use drugs (PWUD)/ Despite, this growing burden the genetic features and transmission patterns of HCV in these settings are poorly understood. This study analyzed 692 HCV antibody-positive specimens collected from rural communities in ten U.S. states. Using amplicon-based deep sequencing and the Global Hepatitis Outbreak and Surveillance Technology (GHOST) platform, transmission networks were reconstructed. Among sequenced individuals, 29.5% were linked within clusters. The structure of these clusters varied by region-from sparse networks in Ohio to dense, interconnected clusters in New England. Phylogenetic analysis revealed that some transmission networks persisted for over a decade, highlighting long-term, sustained transmission. Nearly half of all clusters involved individuals connected through social recruitment, suggesting peer-referral strategies can effectively identify transmission chains. Younger age was independently associated with clustering, while recruitment by an intimate partner showed a weaker link. These findings emphasize the importance of ongoing genomic surveillance and social network-informed strategies to detect emerging HCV clusters and guide targeted public health interventions in underserved rural communities.

Indexed as

clusterhepatitis c viruspersons who use drugstransmission

Identifiers

PMID40585240
PMCPMC12204503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.